Hyperbilirubinemia in newborns

Children Safety and efficacy in children have not been established. Hemolysis, jaundice, and hyperbilirubinemia in newborns, particularly in premature infants, have been reported with vitamin K. These effects may be dose-related. Therefore, do not exceed recommended dose. 

Hyperbilirubinemia in newborn infants is very common and accounts for most of the laboratory testing done in the neonatal period. The greatest challenge to managing neonates with hyperbilirubinemia is the short hospital stay of mothers and infants. The length of stay is as little as 24 h in some cases, which does not allow adequate time for the normal bilirubin rise to occur. This requires the physician to make a diagnosis quickly and accurately but sometimes with only limited laboratory data. 

Chemoprotective agent for cisplatin and cyclophosphamide Hypercalcemia of malignancy Hemophilia A and B Congenital factor XIII deficiency Lennox-Gastaut syndrome Colonic adenomatous polyps Treatment of hepatitis B Corneal ulcers Myelodysplastic syndrome Diagnosing allergy to fire ant Non-Hodgkin s lymphoma Hyperbilirubinemia in newborns unresponsive to phototherapy... 

---